首页> 外文期刊>Journal of Antimicrobial Chemotherapy >Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure
【24h】

Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure

机译:达托霉素对万古霉素中间金黄色葡萄球菌(VISA)和异种VISA(hVISA)的敏感性:对万古霉素治疗失败后治疗的意义

获取原文
           

著录项

  • 来源
    《Journal of Antimicrobial Chemotherapy》 |2011年第5期|p.1057-1060|共4页
  • 作者单位

    Department of Microbiology, Austin Health, Heidelberg, Victoria, Australia|Austin Centre for Infection Research (ACIR), Infectious Diseases Department, Austin Health, Victoria, Australia;

    Department of Microbiology, Austin Health, Heidelberg, Victoria, Australia|Austin Centre for Infection Research (ACIR), Infectious Diseases Department, Austin Health, Victoria, Australia;

    Department of Microbiology, Austin Health, Heidelberg, Victoria, Australia|Austin Centre for Infection Research (ACIR), Infectious Diseases Department, Austin Health, Victoria, Australia;

  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号